Cerebras has revised its IPO terms, aiming to raise $3.5 billion with a valuation of $26.6 billion.

Cerebras has revised its IPO terms, aiming to raise $3.5 billion with a valuation of $26.6 billion.

      Three days after hinting at a potential target of up to $4 billion at a $40 billion valuation, the AI chipmaker has announced the marketing of 28 million shares priced between $115 and $125 each, aligning the deal with its February private valuation rather than exceeding it. Cerebras Systems was set to aim for up to $4 billion in its highly anticipated initial public offering. On Monday, the company submitted an updated prospectus that set a more cautious pricing: 28 million shares within a range of $115 to $125 each, potentially raising up to $3.5 billion at the upper limit.

      At the upper end, the implied valuation approaches $26.6 billion, significantly lower than the figure discussed last week and approximately in line with the $23 billion private valuation Cerebras had after its February Series H funding. This valuation is, by any measure, more realistic. The question remains whether it is realistic enough, which the order book will reveal.

      According to the updated prospectus filed on Monday, Cerebras plans to list on the Nasdaq Global Select Market under the ticker "CBRS," with Morgan Stanley, Citigroup, Barclays, and UBS Investment Bank acting as joint book-running managers. The 28-million-share offering includes an underwriter option for an additional 4.2 million shares, which could increase gross proceeds by about $525 million at the top of the range. CNBC reports that CEO Andrew Feldman, who co-founded the company, will not be selling any shares in the IPO; he will retain 10.3 million shares post-offering, valued at up to $1.28 billion at the peak price.

      The financial underpinnings of the offering are solid for AI hardware standards. Cerebras’s latest quarterly report indicated a year-on-year revenue increase of approximately 76% to $510 million, with net income of $87.9 million. The company’s Master Relationship Agreement with OpenAI, signed in January, assures up to 750 megawatts of inference capacity through 2028, a contract that Cerebras has previously valued at over $20 billion over its duration. This agreement, more than any singular demonstration of wafer-scale technology, has formed the basis of the IPO narrative.

      Why has the valuation decreased? The transition from a potential $4 billion fundraising at a $40 billion valuation to a marketed $3.5 billion at about $26.6 billion is not overly dramatic by IPO standards, but it is still significant. Three possible explanations arise.

      The first is execution. By filing at a wider range and a more reasonable valuation, the risk of having an undersubscribed book at launch decreases, allowing flexibility to increase the price if demand is strong. Given that AI hardware listings have often priced below their initial ranges in the past two years, this cautious approach seems prudent.

      The second reason is market context. AI software multiples have been declining since April, with stocks like Palantir dropping about 30% year-to-date and Citi reducing price targets across the AI platform sector. Although Cerebras is in hardware rather than software, hardware listings have also faced this wider market recalibration. Pricing in accordance with the current public benchmarks for memory and compute is once again a sensible strategy.

      The third consideration is concentration risk. Investors in the public market will recognize that OpenAI is the primary customer for Cerebras's offerings. If OpenAI achieves its projected computing needs, the financial implications are substantial. However, if OpenAI’s demand for compute shifts even slightly, Cerebras's short-term revenue expectations could also adjust. This risk is present at a $26.6 billion valuation, but it is easier to manage at that level than at $40 billion.

      What the pricing might imply: If Cerebras prices at the high end of the indicated range, it would be among the largest technology IPOs in the U.S. for 2026, preceding any new entrants in AI silicon since Nvidia's resurgence in the public market three years ago. Reuters and IFR have noted that this deal represents a roughly $3 billion raise in Nasdaq IPO terms; the exact amount will depend on whether the underwriter's overallotment is utilized and the final pricing. Regardless, this marks the largest initial public capital event in specialized AI training and inference hardware to date.

      Additionally, this offering would serve as a public test of a thesis Cerebras has meticulously developed over the past decade: that its wafer-scale chip, an architecturally innovative alternative to clustering numerous smaller GPUs on a single board, is now viable for large-scale commercial application. The OpenAI contract represents the most significant endorsement of that thesis, and the IPO, if priced accordingly, serves as another testament.

      The journey from filing to first trade is not simply procedural. Cerebras's previous IPO attempt in 2024 fell through after the Committee on Foreign Investment in the United States began reviewing G42’s stake in the company, but the subsequent restructuring of that stake into non-v

Other articles

Cerebras has revised its IPO terms, aiming to raise $3.5 billion with a valuation of $26.6 billion.

Cerebras submitted a revised prospectus aiming for a $3.5 billion raise at a valuation of $26.6 billion, significantly lower than the $40 billion figure mentioned last week.